High impact
Agios Pharmaceutical shares rose this week on expectations of accelerated approval for its sickle cell disease drug.
Finnhub07/10, 06:55 PM
Your privacy choice
S7 Markets works without measurement. If you allow it, we count which screens are opened and which actions are taken, on our own domain and never anything you typed. You can change this in Settings at any time.
Read the privacy policyNews story
High impact
Finnhub07/10, 06:55 PM